요관 스텐트 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 지역별, 부문별 예측(2025-2030년)

Ureteral Stents Market Growth & Trends:

The global ureteral stents market size is anticipated to reach USD 853.3 million by 2030, expanding at a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Rising incidence of urological diseases such as kidney stones, urinary incontinence, tumors is driving the market. Ureteral stents help in restoring the flow of urine through the blocked ureters and are utilized during urological surgeries to maintain the patency of the ureter. These are used for several medical conditions such as kidney stones, urinary incontinence, and kidney transplants. Thus, with the mounting prevalence of these incidences, the market is anticipated to witness a significant growth rate over the forecast period.

In addition, the geriatric population is at higher risk to develop urological and kidney-related issues such as kidney stones. Thus, the growing geriatric population is expected to drive the market. For instance, as per the WHO report 2018, the world base of population pertaining to the age group of 60 and above is anticipated to reach 2.0 billion by 2050 from 900.0 million in 2015. This is expected to propel market growth over the forecast period.

Furthermore, the incorporation of new technologies and introduction of new products by market players are expected to boost the market growth. For instance, in 2019, Boston Scientific has unveiled the LithoVue Empower retrieval deployment device which is utilized with company's single-use digital flexible ureteroscope during kidney stone retrieval procedures.

Ureteral Stents Market Report Highlights:

• Based on material, the polymer stents segment dominated the market with a share of 67.0% in 2024 owing to the high adoption of these stents during urological procedures due to its reduced rate of complications and infections
• On the basis of application, the kidney stones segment dominated the market with a share of 37.0% in 2024. This is due to an increase in the adoption of a sedentary lifestyle such as dietary habits that leads to kidney stones and associated surgeries
• North America dominated the market with the highest revenue share of 36.3% in 2024 owing to the increasing kidney-related illnesses, and availability of the latest treatment procedures in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Ureteral Stents Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Ureteral Stents Market: Material Business Analysis

• 4.1. Material Market Share, 2024 & 2030
• 4.2. Material Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Material, 2018 to 2030 (USD Million)
• 4.4. Metallic Ureteral Stents
  • 4.4.1. Metallic Ureteral Stents Market, 2018 - 2030 (USD Million)
• 4.5. Polymer Ureteral Stents
  • 4.5.1. Polymer Ureteral Stents Market, 2018 - 2030 (USD Million)
  • 4.5.2. Silicone Stents
    • 4.5.2.1. Silicone Stents Market, 2018 - 2030 (USD Million)
  • 4.5.3. Polyurethane Stents
    • 4.5.3.1. Polyurethane Stents Market, 2018 - 2030 (USD Million)
  • 4.5.4. Hybrid Stents
    • 4.5.4.1. Hybrid Stents Market, 2018 - 2030 (USD Million)

Chapter 5. Ureteral Stents Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Kidney Stones
  • 5.4.1. Kidney Stones Market, 2018 - 2030 (USD Million)
• 5.5. Kidney Transplantation
  • 5.5.1. Kidney Transplantation Market, 2018 - 2030 (USD Million)
• 5.6. Tumors
  • 5.6.1. Tumors Market, 2018 - 2030 (USD Million)
• 5.7. Urinary Incontinence
  • 5.7.1. Urinary Incontinence Market, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Ureteral Stents Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Allium Medical
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Material Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. B.Braun Melsungen AG
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Material Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Becton, Dickinson and Company
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Material Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Boston Scientific Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Material Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Coloplast
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Material Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Cook Medical
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Material Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Olympus Corporation
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Material Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Pnn Medical A/S
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Material Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Teleflex Inc.
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Material Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Merit Medical Systems, Inc.
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Material Benchmarking
    • 7.5.10.4. Strategic Initiatives